The Ensign Group, Inc.
NASDAQ:ENSGMedical - Care Facilities
-$1.09 today
- Market cap
- $10.68B
- Beta
- 0.68
- P/E (TTM)
- 24.8
- EPS (TTM)
- $6.29
- Dividend yield
- 0.16%
Volume 0.27M
Average 0.56M
ENSG Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
The Ensign Group, Inc.NASDAQ: ENSG
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables turns negative
Q2 FY2026 accounts receivables was -$5.61M, compared with $5.56M a year earlier. Trailing-twelve-month accounts receivables was -$91.03M. Over 3 fiscal years it compounded at -5.1% a year.
Context
- Accounts receivables amounted to 1.4% of revenue in FY2025, down 0.6 pp from a year earlier.
- Accounts receivables grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -$5.61M or moves back toward the trailing-twelve-month quarterly average of -$22.76M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (70.43M) USD
- Year-over-year change
- +16.5%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (70.43M) | +16.5% |
| FY2024 | 2024-12-31 | (84.4M) | -5.7% |
| FY2023 | 2023-12-31 | (79.82M) | +3.2% |
| FY2022 | 2022-12-31 | (82.43M) | -167.9% |
| FY2021 | 2021-12-31 | (30.77M) | — |
Accounts Receivables vs competitors
How ENSG compares with its peers on the latest reported figures
- ENSG's LTM Jun 2026 accounts receivables of $91.03M is the 2nd largest of the 11 companies compared; the peer median is $261.5K.
- Its year-over-year change of +197.4% is the 6th highest of 11, against a peer median of +184.6%.
- Accounts receivables amounts to 1.7% of revenue for ENSG, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.83B | +843.8% | -51.0% | 2.3% | |
| LTM Jun 2026 | $91.03M | +197.4% | -5.1% | 1.7% | |
| LTM Jun 2026 | $62.9M | +362.5% | -3.5% | 1.0% | |
| LTM Jun 2026 | $18.69M | -68.5% | — | 0.3% | |
| LTM Oct 2026 | $16.53M | +166.8% | +110.8% | 0.6% | |
| LTM Sep 2026 | $14.92M | +202.5% | +50.6% | 0.5% | |
| LTM Mar 2026 | $10.3M | -57.9% | +305.9% | 1.0% | |
| LTM Sep 2026 | $8.96M | +344.5% | -1.6% | 0.6% | |
| LTM Mar 2026 | $6M | +103.9% | +65.1% | 0.0% | |
| LTM Jun 2026 | $4.85M | +1224.0% | +68.7% | 0.2% | |
| LTM Mar 2026 | $4.32M | +141.8% | — | 0.5% | |
| Peer median (excluding ENSG) | $261.5K | +184.6% | +57.8% | 0.5% | |
Competitors are the stored peer set for ENSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 197.73M | 224.65M | 209.85M | 298.46M | 344.26M |
| Depreciation & Amortization | 55.99M | 62.36M | 72.39M | 84.14M | 104.33M |
| Deferred Income Tax | (24.88M) | (6.5M) | (27.48M) | 635K | (16.86M) |
| Stock-Based Compensation | 18.68M | 22.72M | 30.77M | 36.23M | 48.3M |
| Change in Working Capital | 33K | (36.94M) | 37.89M | (75.16M) | 77.92M |
| Accounts Receivables | (30.77M) | (82.43M) | (79.82M) | (84.4M) | (70.43M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 7.12M | 17.87M | 15.92M | 2.84M | (2.92M) |
| Other Working Capital | 23.69M | 27.61M | 101.79M | 6.41M | 151.28M |
| Other Non-Cash Items | 28.14M | 6.23M | 53.25M | 2.89M | 6.31M |
| Operating Cash Flow | 275.68M | 272.51M | 376.67M | 347.19M | 564.27M |
| Capital Expenditures | (69.55M) | (87.55M) | (106.18M) | (158.24M) | (193.56M) |
| Acquisitions (Net) | (7.98M) | (16.4M) | 0 | 0 | 0 |
| Purchases of Investments | (32.26M) | (21.98M) | (30.82M) | (105.15M) | (110.72M) |
| Sales of Investments | 27.48M | 14.36M | 18.85M | 26.4M | 99.67M |
| Other Investing Activities | (91.6M) | (74.62M) | (64.55M) | (153.06M) | (308.57M) |
| Investing Cash Flow | (173.91M) | (186.18M) | (182.7M) | (390.05M) | (513.18M) |
| Debt Repayment | 42.16M | (3.7M) | (3.88M) | (3.95M) | (4.09M) |
| Common Stock Issued | 0 | 6.69M | 0 | 0 | 29.04M |
| Common Stock Repurchased | (11.83M) | (31.58M) | (1.93M) | (1.21M) | (21.43M) |
| Dividends Paid | (11.55M) | (12.17M) | (12.89M) | (13.67M) | (14.41M) |
| Other Financing Activities | (94.92M) | 2.51M | 18.09M | 16.67M | (924K) |
| Financing Cash Flow | (76.14M) | (32.26M) | (612K) | (2.16M) | (11.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.64M | 54.07M | 193.36M | (45.03M) | 39.28M |
| Free Cash Flow | 206.13M | 184.97M | 270.49M | 188.95M | 370.71M |
The Ensign Group, Inc.
NASDAQ:ENSG
Intrinsic Alpha fair value
Locked
Current Price
$182.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.